APRIL WINKLER: Open Payments
NPI 1104273861 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 39 payments from 15 companies in 2025. Trend: 2023 $354 · 2024 $382 · 2025 $778
Food & beverage: $766Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $264 |
| AstraZeneca Pharmaceuticals LP | 5 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| PFIZER INC. | 2 | $28 |
| Radius Health, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, BREZTRI, CAPLYTA, JOURNAVX, Jornay PM, NURTEC ODT, UBRELVY, Tymlos.
Industry payments across MO — which companies pay providers there.
